Long-Term Inhibition of HIV-1 Infection in Primary Hematopoietic Cells by Lentiviral Vector Delivery of a Triple Combination of Anti-HIV shRNA, Anti-CCR5 Ribozyme, and a Nucleolar-Localizing TAR Decoy
Open Access
- 1 November 2005
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 12 (5) , 900-909
- https://doi.org/10.1016/j.ymthe.2005.07.524
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Gene silencing by lentivirus-mediated delivery of siRNA in human CD34+ cellsBlood, 2004
- RNA interference against retrovirusesVirus Research, 2004
- Control of HIV-1 replication by RNA interferenceVirus Research, 2004
- Knockdown by RNAi-proceed with caution.Nature Biotechnology, 2004
- Induction of an interferon response by RNAi vectors in mammalian cellsNature Genetics, 2003
- Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction as a Method for Determining Lentiviral Vector Titers and Measuring Transgene ExpressionHuman Gene Therapy, 2003
- RNA interference of HIV replicationTrends in Immunology, 2002
- Downregulation of the CCR5 β-Chemokine Receptor and Inhibition of HIV-1 Infection by Stable VA1-Ribozyme Chimeric TranscriptsAntisense and Nucleic Acid Drug Development, 2000
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996